[{"ATTACHMENTNAME":"19b6f78a-b75c-4423-a9d8-f8d1b60f77dc.pdf","NEWS_DT":"2022-11-21T14:18:26.913","QUARTER_ID":null,"CATEGORYNAME":"Company Update","HEADLINE":"Pursuant to Regulation 30 and 46 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and with reference to our letter dated 7th November, 2022, intimating you about the earning conference call for Q2 & H1 FY23 with Analysts/Investors held on 16th November, 2022, please find attached herewith the transcript of the aforesaid conference call.\r\n\r\nThe above information is also available on the website of the Company at https://www.themismedicare.com \r\n","SCRIP_CD":530199,"AGENDA_ID":157,"NEWSSUB":"Announcement under Regulation 30 (LODR)-Earnings Call Transcript"}]